[Clarkson syndrome: a rare clinical condition characterized by generalized edema associated to monoclonal gammopathy]

Recenti Prog Med. 2005 Oct;96(10):488-91.
[Article in Italian]

Abstract

Generalized edema is commonly due to cardiac failure, renal changes, hepatic and metabolic disturbances, or it can be idiopathic, i.e. primitive lymphedema. Here we describe a patient with several episodes of fluid extravasation characterized by hypotension, hemoconcentration and functional renal insufficiency. These findings, associated to a monoclonal gammopathy, lead to the diagnosis of systemic capillary leak syndrome or Clarkson Syndrome. This rare and perplexing disorder, characterized by a typical three-phase clinical feature, is due to an endothelium permeability alteration, rather responsible of these paroxysmal manifestations. Interleukin-2-pathway is considered as one of the underlying mechanisms. During acute phase the patient underwent therapy with plasma-expanders and glucocorticoids, although in quiescent phase we administered aminophylline, salbutamol and prednisone. After three months, the patient is asymptomatic.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adrenergic beta-Agonists / therapeutic use
  • Albuterol / therapeutic use
  • Aminophylline / therapeutic use
  • Angioedema / diagnosis*
  • Angioedema / immunology
  • Angioedema / physiopathology
  • Angioedema / therapy
  • Anti-Inflammatory Agents / therapeutic use
  • Blood Transfusion
  • Capillary Leak Syndrome / diagnosis*
  • Capillary Leak Syndrome / immunology
  • Capillary Leak Syndrome / physiopathology
  • Capillary Leak Syndrome / therapy
  • Capillary Permeability
  • Cardiotonic Agents / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Interleukin-2 / metabolism
  • Male
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance / diagnosis*
  • Monoclonal Gammopathy of Undetermined Significance / immunology
  • Monoclonal Gammopathy of Undetermined Significance / physiopathology
  • Monoclonal Gammopathy of Undetermined Significance / therapy
  • Prednisone / therapeutic use
  • Treatment Outcome

Substances

  • Adrenergic beta-Agonists
  • Anti-Inflammatory Agents
  • Cardiotonic Agents
  • Interleukin-2
  • Aminophylline
  • Albuterol
  • Prednisone